Clene Inc.
For the period ended Dec 3, 2025. Filed Dec 3, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Dec 3, 2025 · Filed Dec 3, 2025
Use the contents to explore the available documents and sections.
CLNN$3.95-0.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Title: CNM-Au8 ALS Program Update
Title: CNM-Au8 ALS Program Update
Presenters: Rob Etherington, CEO and President; Dr. Ben Greenberg, Head of Medical; Michael Hotchkin, Chief Development Officer, and a KOL
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.